Intermolecular (IMI) Reports In-Line Q4 EPS, Q1 EPS Guidance Misses

Intermolecular (NASDAQ: IMI) reported Q4 EPS of ($0.10), in-line with the analyst estimate of ($0.10). Revenue for the quarter came in at $11 million versus the consensus estimate of $10.4 million.

Intermolecular sees Q1 2015 EPS of ($0.12)-($0.14), versus the consensus of ($0.08). Intermolecular sees Q1 2015 revenue of $9.0-10.0 million, versus the consensus of $10.83 million.

For earnings history and earnings-related data on Intermolecular (IMI) click here.

You May Also Be Interested In

• Lockheed Martin (LMT) Tops Q1 EPS by 53c, Beats on Revenue; Offers FY24 Guidance
• Philip Morris International (PM) Tops Q1 EPS by 9c; raises guidance
• Sherwin-Williams (SHW) Misses Q1 EPS by 5c, provides guidance